As of June 2022 Ligand Pharmaceuticals has a market cap of $1.46 Billion. This makes Ligand Pharmaceuticals the world's 3864th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $1.50 B | -41.67% |
2021 | $2.58 B | 61.4% |
2020 | $1.59 B | -8.85% |
2019 | $1.75 B | -37.74% |
2018 | $2.81 B | -2.49% |
2017 | $2.88 B | 36.08% |
2016 | $2.12 B | -1.81% |
2015 | $2.16 B | 107.65% |
2014 | $1.04 B | -3.26% |
2013 | $1.07 B | 143.96% |
2012 | $0.44 B | 88.98% |
2011 | $0.23 B | 34.2% |
2010 | $0.17 B | -31.26% |
2009 | $0.25 B | -2.69% |
2008 | $0.26 B | -42.87% |
2007 | $0.45 B | -58.2% |
2006 | $1.08 B | 33.71% |
2005 | $0.81 B | -4.09% |
2004 | $0.84 B | -21% |
2003 | $1.07 B | 180.23% |
2002 | $0.38 B | -64.33% |
2001 | $1.07 B |
On Jun 28th, 2022 the market cap of Ligand Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $467.37 B | 31,751.61% | ๐บ๐ธ USA |
![]() Pfizer PFE | $286.46 B | 19,422.51% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $306.79 B | 20,807.86% | ๐บ๐ธ USA |
![]() Amgen AMGN | $131.63 B | 8,870.57% | ๐บ๐ธ USA |
![]() Baxter BAX | $33.56 B | 2,187.78% | ๐บ๐ธ USA |
![]() Merck MRK | $233.45 B | 15,810.25% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $166.82 B | 11,268.93% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $111.37 B | 7,490.44% | ๐ฌ๐ง UK |
![]() Spectrum Pharmaceuticals
SPPI | $0.14 B | -90.17% | ๐บ๐ธ USA |